The US private equity firm is working with an investment bank as it considers selling about $750 million worth of stock in the Indian-listed company known as JB Pharma, the people said, asking not to be identified because the matter is private.
The US private equity firm is working with an investment bank as it considers selling about $750 million worth of stock in the Indian-listed company known as JB Pharma, the people said, asking not to be identified because the matter is private.